Nabriva Therapeutics plc

NasdaqCM:NBRV Stock Report

Mkt Cap: US$5.4m

Nabriva Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:NBRV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Aug 22SellUS$1,956Mark H. CorriganIndividual411.88US$4.75
02 Aug 22SellUS$1,487Stephen WebsterIndividual313.04US$4.75
02 Aug 22SellUS$1,015Colin BroomIndividual213.56US$4.76
02 Aug 22SellUS$2,156Daniel BurgessIndividual453.64US$4.75
01 Aug 22SellUS$1,487Carrie BourdowIndividual341.6US$4.35
01 Aug 22SellUS$1,487Charles RowlandIndividual339.84US$4.38

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NBRV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders31,6461.0%
Institutions90,6503.0%
VC/PE Firms180,5045.9%
General Public2,761,14790.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35%.


Top Shareholders

Top 25 shareholders own 9.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.89%
Lincoln Park Capital, LLC
180,504$317.7k0%4.08%
0.84%
Values First Advisors, Inc.
25,868$45.5k-0.09%0.03%
0.67%
Renaissance Technologies LLC
20,561$36.2k-35.42%no data
0.56%
Frazier Life Sciences Management, LP
17,025$30.0k-0.01%no data
0.47%
Steven Gelone
14,423$25.4k-0.18%no data
0.46%
Universal-Investment-Gesellschaft Mit BeschrÄNkter Haftung
14,000$24.6k0%no data
0.41%
Theodore Schroeder
12,420$21.9k-0.43%no data
0.15%
Morgan Stanley, Investment Banking and Brokerage Investments
4,477$7.9k-2.84%no data
0.14%
Medical Strategy GmbH, Asset Management Arm
4,389$7.7k0%no data
0.065%
Triad Hybrid Solutions, LLC
2,000$3.5k0%no data
0.056%
Geode Capital Management, LLC
1,709$3.0k0%no data
0.048%
Colin Broom
1,461$2.6k65.27%no data
0.023%
Independent Financial Partners
700$1.2k0%no data
0.02%
Charles Rowland
611$1.1k143.43%no data
0.015%
Stephen Webster
458$806.1545.07%no data
0.014%
Daniel Burgess
415$730.4145.56%no data
0.013%
Carrie Bourdow
397$698.7917.95%no data
0.012%
UBS Asset Management
381$670.6-69.91%no data
0.012%
Lisa Dalton
364$640.60%no data
0.01%
Robert Crotty
305$536.80%no data
0.0094%
Mark H. Corrigan
288$506.90%no data
0.0091%
J. Naftzger
280$492.80%no data
0.0073%
Jennifer Schranz
224$394.20%no data
0.0017%
Merrill Lynch & Co. Inc., Banking Investments
52$91.5-27.78%no data
0.00065%
RBC Dominion Securities Inc., Asset Management Arm
20$35.20%no data